🔹 Revenue: $1.394B (est. $1.38B) 🟢
🔹 Non-GAAP EPS: $3.08 (est. $3.03) 🟢
🔹 Organic CC growth: +7.1% y/y
Guidance
🔹 FY25 Revenue: $5.43B–$5.445B (est. $5.41B) 🟢
🔹 FY25 Non-GAAP EPS: $11.36–$11.44 (est. $11.14) 🟢
🔹 Q4 Revenue: $1.38B–$1.40B (est. $1.37B) 🟢
🔹 Q4 Non-GAAP EPS: $3.10–$3.18 (est. $2.91) 🟢
Other Q3 Metrics:
🔹 Op margin (non-GAAP): 16.0%
🔹 New $1B buyback authorization
🔹 Cash & equivalents: $1.244B (9/30/25)